Sung-han Y. Hsiao

Taoyuan, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Respiratory microbiome and metabolome features associate disease severity and the need for doxycycline treatment in children with macrolide-resistant Mycoplasma pneumoniae-mediated pneumonia.

Respiratory microbiome and metabolome features associate disease severity and the need for doxycycline treatment in children with macrolide-resistant Mycoplasma pneumoniae-mediated pneumonia.

Journal: Frontiers in cellular and infection microbiology

Published: November 30, 2024

Epidermal Growth Factor Receptor Inhibitor Mobocertinib Resensitizes Multidrug-Resistant Cancer Cells by Attenuating the Human ATP-Binding Cassette Subfamily B Member 1 and Subfamily G Member 2.

Epidermal Growth Factor Receptor Inhibitor Mobocertinib Resensitizes Multidrug-Resistant Cancer Cells by Attenuating the Human ATP-Binding Cassette Subfamily B Member 1 and Subfamily G Member 2.

Journal: ACS pharmacology & translational science

Published: September 02, 2023

Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells.

Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells.

Journal: International journal of molecular sciences

Published: August 21, 2023

Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2.

Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: July 29, 2023

Relatively preserved functional immune capacity with standard COVID-19 vaccine regimen in people living with HIV.

Relatively preserved functional immune capacity with standard COVID-19 vaccine regimen in people living with HIV.

Journal: Frontiers in immunology

Published: April 12, 2023

The origin of regulatory from the effector cells in LAG-3-marked Th1 immunity against severe influenza virus infection.

The origin of regulatory from the effector cells in LAG-3-marked Th1 immunity against severe influenza virus infection.

Journal: Immunology

Published: September 20, 2022

An IL-17-EGFR-TRAF4 axis contributes to the alleviation of lung inflammation in severe influenza.

An IL-17-EGFR-TRAF4 axis contributes to the alleviation of lung inflammation in severe influenza.

Journal: Communications biology

Published: September 11, 2022

Branebrutinib (BMS-986195), a Bruton's Tyrosine Kinase Inhibitor, Resensitizes P-Glycoprotein-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Agents.

Branebrutinib (BMS-986195), a Bruton's Tyrosine Kinase Inhibitor, Resensitizes P-Glycoprotein-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Agents.

Journal: Frontiers in cell and developmental biology

Published: April 23, 2021

Overexpression of Human ABCB1 and ABCG2 Reduces the Susceptibility of Cancer Cells to the Histone Deacetylase 6-Specific Inhibitor Citarinostat.

Overexpression of Human ABCB1 and ABCG2 Reduces the Susceptibility of Cancer Cells to the Histone Deacetylase 6-Specific Inhibitor Citarinostat.

Journal: International journal of molecular sciences

Published: February 04, 2021

The third-generation EGFR inhibitor almonertinib (HS-10296) resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs.

The third-generation EGFR inhibitor almonertinib (HS-10296) resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs.

Journal: Biochemical pharmacology

Published: December 22, 2020

Erdafitinib Resensitizes ABCB1-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs.

Erdafitinib Resensitizes ABCB1-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs.

Journal: Cancers

Published: May 11, 2020

Licochalcone A Selectively Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs.

Licochalcone A Selectively Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs.

Journal: Journal of natural products

Published: April 30, 2020

Showing 1-12 of 33

Last Updated: 09/26/2026